Cargando…
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression
Introduction: The BORIS, 11 zinc-finger transcription factors, is a member of the cancer-testis antigen (CTA) family. It is mapped to chromosome number 20q13.2 and this region is genetically linked to the early onset of breast cancer. The current study analyzed the correlation between BORIS mutation...
Autores principales: | Akhtar, Mohammad Salman, Akhter, Naseem, Talat, Arshi, Alharbi, Raed A., Sindi, Abdulmajeed A.A., Klufah, Faisal, Alyahyawi, Hanan E., Alruwetei, Abdulmohsen, Ahmad, Abrar, Zamzami, Mazin A., Deo, SVS, Husain, Syed Akhtar, Badi, Osama A., Khan, Mohammad Jahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219660/ https://www.ncbi.nlm.nih.gov/pubmed/37235839 http://dx.doi.org/10.18632/oncotarget.28442 |
Ejemplares similares
-
Association of mutation and low expression of the CTCF gene with breast cancer progression
por: Akhtar, Md. Salman, et al.
Publicado: (2020) -
Epigenetic Alteration and its Association With Downregulated FOXP3 Gene in Indian Breast Cancer Patients
por: Sadaf,, et al.
Publicado: (2021) -
Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer
por: Zhang, Yanmei, et al.
Publicado: (2017) -
Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia
por: Almalki, Shaia S R, et al.
Publicado: (2023) -
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy
por: Asano, Takuya, et al.
Publicado: (2016)